Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Mbanya

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Patient Access To Life-Saving Medication; Preventing Stock-Outs Due To Parallel TradeM Ratcliffe, Z Mbanya, V Gielen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Expanded Data Sets For Hta Decision-Making In Oncology: Do They Help To Achieve Positive Appraisals?S Chadda, Z Mbanya, V Gielen, et al.
ESMO Open|May 29, 2025
Patient-reported outcomes with trastuzumab deruxtecan in hormone receptor-positive, HER2-low or HER2-ultralow metastatic breast cancer: results from the randomized DESTINY-Breast06 trialX Hu, G Curigliano, K Yonemori, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Patient Access To Life-Saving Medication; Preventing Stock-Outs Due To Parallel TradeM Ratcliffe, Z Mbanya, V Gielen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Expanded Data Sets For Hta Decision-Making In Oncology: Do They Help To Achieve Positive Appraisals?S Chadda, Z Mbanya, V Gielen, et al.
ESMO Open|May 29, 2025
Patient-reported outcomes with trastuzumab deruxtecan in hormone receptor-positive, HER2-low or HER2-ultralow metastatic breast cancer: results from the randomized DESTINY-Breast06 trialX Hu, G Curigliano, K Yonemori, et al.
Pageof 1